Maiko Tanaka

Mogamulizumab versus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial

Youn H. Kim, M. Bagot, Lauren Pinter‐Brown et al. · The Lancet Oncology · 2018 · 645 citations · Full text

Medicine, Oncology, Pharmacotherapy +13

Regulatory mechanisms for the production of BAFF and IL-6 are impaired in monocytes of patients of primary Sjögren's syndrome

Keiko Yoshimoto, Maiko Tanaka, Masako Kojima et al. · Arthritis Research & Therapy · 2011 · 77 citations · Full text

Medicine, Immunology, Pathology +13

Hexameric and pentameric complexes of the ExbBD energizer in the Ton system

Saori Maki-Yonekura, Rei Matsuoka, Yoshiki Yamashita et al. · eLife · 2018 · 61 citations · Full text

Life Sciences, Biochemistry, Biology +17

A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer’s disease and tauopathy in mice

Tomohiro Onishi, Ryouta Maeda, Michiko Terada et al. · Scientific Reports · 2021 · 56 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17

TAK-071, a novel M1 positive allosteric modulator with low cooperativity, improves cognitive function in rodents with few cholinergic side effects

Yuu Sako, Emi Kurimoto, Takao Mandai et al. · Neuropsychopharmacology · 2018 · 55 citations · Full text

Life Sciences, Neuroscience, Pharmacology +17